Updated Jul 16, 2026
Cummings James F. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
James F. Cummings is a medical professional currently serving as the Chief Medical Officer at Vaxart, Inc., a biotechnology company focused on developing oral vaccines. His role involves overseeing clinical development and medical affairs related to the company's vaccine pipeline.
| Role | Chief Medical Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | VXRT | Vaxart, Inc. | F — Tax withholding / forfeiture | 3.3K | $0.65 | $2K |
| 2026-03-26 | VXRT | Vaxart, Inc. | F — Tax withholding / forfeiture | 30.6K | $0.69 | $21K |
| 2026-03-20 | VXRT | Vaxart, Inc. | F — Tax withholding / forfeiture | 6.8K | $0.63 | $4K |
| 2026-03-18 | VXRT | Vaxart, Inc. | A — Grant or award | 227.0K | $0.00 | |
| 2026-02-05 | VXRT | Vaxart, Inc. | F — Tax withholding / forfeiture | 8.0K | $0.61 | $5K |
James F. Cummings is a medical professional currently serving as the Chief Medical Officer at Vaxart, Inc., a biotechnology company focused on developing oral vaccines. His role involves overseeing clinical development and medical affairs related to the company's vaccine pipeline.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Cummings James F. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.